FDA Inspection
Muzaffar H. Qazilbash, M.D.Muzaffar H. Qazilbash, M.D. – FDA Inspection, Oct 14, 2011
Record Details
This FDA Inspection record concerns Muzaffar H. Qazilbash, M.D., with an inspection on October 14, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Muzaffar H. Qazilbash, M.D.
- Inspection Date
- October 14, 2011
- Product Type
- Biologics
View Company Profile
ID · 0e8e69d9-eb07-4433-a856-58fb36633d6e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 748885
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.68FDA access to clinical investigator records
- 21 CFR 312.66Unanticipated problems
- 21 CFR 312.64(b)Safety reports
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Muzaffar H. Qazilbash, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 16, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Muzaffar H. Qazilbash, M.D.
- FDA Inspection 998990 - 2016-11-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.